Pharsight

Minolira patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11103517 EPI HLTH Pharmaceutical compositions for minocycline
Apr, 2036

(12 years from now)

Minolira is owned by Epi Hlth.

Minolira contains Minocycline Hydrochloride.

Minolira has a total of 1 drug patent out of which 0 drug patents have expired.

Minolira was authorised for market use on 08 May, 2017.

Minolira is available in tablet, extended release;oral dosage forms.

The generics of Minolira are possible to be released after 07 April, 2036.

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Market Authorisation Date: 08 May, 2017

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

MINOLIRA family patents

Family Patents